Cost effectiveness of mosunetuzumab and CAR-T cell therapy in relapsed/refractory follicular lymphoma.
Saved in:
| Title: | Cost effectiveness of mosunetuzumab and CAR-T cell therapy in relapsed/refractory follicular lymphoma. |
|---|---|
| Authors: | Lin, Meng-Hsuan1 (AUTHOR), Weiss, Jonathan2 (AUTHOR), Phillips, Tycel J.3 (AUTHOR), Sano, Dahlia2 (AUTHOR), Carty, Shannon A.2 (AUTHOR), Wilcox, Ryan2 (AUTHOR), Ghosh, Monalisa2 (AUTHOR), Ahmed, Iman2 (AUTHOR), Nachar, Victoria R.2 (AUTHOR), Hutton, David1 (AUTHOR), Karimi, Yasmin H.2 (AUTHOR) karimiy@med.umich.edu |
| Source: | Leukemia & Lymphoma. Oct2025, Vol. 66 Issue 10, p1850-1862. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
